Comparison of naratriptan and sumatriptan in recurrence-prone migraine patients
- 31 August 2000
- journal article
- Published by Elsevier in Clinical Therapeutics
- Vol. 22 (8) , 981-989
- https://doi.org/10.1016/s0149-2918(00)80069-7
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Naratriptan is effective and well tolerated in the acute treatment of migraineNeurology, 1997
- Naratriptan is Effective and Well Tolerated in the Acute Treatment of Migraine. Results of a Double‐Blind, Placebo‐Controlled, Parallel‐Group StudyHeadache: The Journal of Head and Face Pain, 1997
- NaratriptanCephalalgia, 1997
- Evaluation of the Long-Term Safety and Efficacy of 311C90 in the Treatment of MigraineEuropean Neurology, 1996
- Oral Sumatriptan: Effect of a Second Dose, and Incidence and Treatment of Headache RecurrencesCephalalgia, 1994
- Alternative approaches to the analysis of binary and categorical repeated measurementsJournal of Biopharmaceutical Statistics, 1992
- Oral sumatriptan in acute migraineThe Lancet, 1991
- A Randomized, Double-Blind Comparison of Sumatriptan and Cafergot in the Acute Treatment of MigraineEuropean Neurology, 1991
- Evaluation of a Multiple-Dose Regimen of Oral Sumatriptan for the Acute Treatment of MigraineEuropean Neurology, 1991
- Sumatriptan An Oral Dose-Defining StudyEuropean Neurology, 1991